New sales orders for 765 kSEK (68 kEUR) for Bilberry extracts

Eevia Health Plc (”Eevia” or ”The Company”) has received two sales orders for a total of 68 KEUR (765 KSEK) from two European customers for Feno-Myrtillus® organic extracts.

Eevia received the sales order from two European customers. One is a brand holder selling a bilberry supplement brand in several European countries. The other is an ingredient reseller in France, which Eevia has worked with for some years.

The products are two of Eevia’s branded ingredients under the tradename Feno-Myrtillus® Organic and the value is 68 KEUR (765 KSEK).

These orders are repeat orders from two stable customers, both of whom are experiencing growing sales. This demonstrates the trust and loyalty these customers have in Eevia's products. Eevia has bilberry extracts in stock and will ship the orders immediately to the customers. Sales from inventory have a very positive impact on cash flow from operations. Eevia expects growing repeat orders from both customers, further solidifying these business relationships.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          

Email: stein.ulve@eeviahealth.com  or investor@eeviahealth.com                     

Telephone: +358 400 22 5967                         

INFORMATION ABOUT EEVIA HEALTH PLC

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested sustainably.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. In June 2021, Eevia listed its shares on the Spotlight Stock Market in Sweden under the short name (ticker) EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.